Key result
Systemic scleroderma without evident heart disease was associated with increased premature supraventricular and ventricular contractions and decreased heart rate variability compared to controls.
Why the study?
Do noninvasive electrocardiographic methods detect early subclinical heart involvement in patients with systemic scleroderma?
Case-Control (n=27)
Do noninvasive electrocardiographic methods detect early subclinical heart involvement in patients with systemic scleroderma?
Answers are grounded in this paper and cite their sources.
Noninvasive electrocardiographic evaluation, including Holter monitoring and HRV analysis, is useful for detecting early, subclinical cardiac involvement in patients with systemic scleroderma.
BACKGROUND: In patients with systemic scleroderma (SSc), clinically evident cardiac involvement is recognized to be a poor prognostic factor. The aim of the study was to evaluate electrocardiographic changes, parameters of heart rate variability (HRV), and heart rate turbulence (HRT) in patients with SSc without evident symptoms of heart disease. METHODS: A group of 27 patients with SSc were subjected to standard electrocardiography (ECG) examination and 24-hour Holter monitoring. Analysis of HRV in time and frequency domains, HRT, and echocardiography were also performed. RESULTS: Holter monitoring revealed a larger number of premature supraventricular contractions (PSVCs), as well as premature ventricular contractions (PVCs) in the patients with systemic scleroderma, as compared with the control group. Moreover, the SSc patients showed decreased parameters of time and frequency domains, as referred to the controls, especially during night hours. In four patients, abnormal HRT values were present. On echocardiography, only slight changes were found, however in five patients left ventricle diastolic dysfunction was diagnosed. CONCLUSIONS: The noninvasive electrocardiographic methods seems to be useful for detecting early heart involvement in course of SSc and could be recommended for routine used in clinical practice. Significance of HRT analysis in patients with SSc needs further elucidation.
No takes yet. Share an insight, caveat, or question.
Biełous‐Wilk et al. (2009) conducted a case-control in Systemic scleroderma (n=27). Systemic scleroderma vs. Control group was evaluated on Electrocardiographic changes, parameters of heart rate variability (HRV), and heart rate turbulence (HRT). Systemic scleroderma without evident heart disease was associated with increased premature supraventricular and ventricular contractions and decreased heart rate variability compared to controls.
Synapse has enriched 10 related papers. Consider them for comparative context: